Amedisys, Inc.
AMED
Rang in Aktien
#4614
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Aktienkurs
$100.99
Zuletzt synchronisiert: 2025-08-15
Marktkapitalisierung
$3.31B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Amedisys, Inc. (AMED)
Kategorie
Healthcare
Operative Marge für Amedisys, Inc. (AMED)
Operative Marge zum October 2026 TTM: 4.03%
Laut den neuesten Finanzberichten und dem Aktienkurs von Amedisys, Inc. beträgt die aktuelle operative Marge (TTM) 4.03%. Am Ende des Jahres 2023 lag die operative Marge bei 6.99%.
Historie der operativen Marge von Amedisys, Inc. von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 4.03% | 0.00% |
| 2024 | 4.03% | -42.35% |
| 2023 | 6.99% | -14.02% |
| 2022 | 8.13% | -28.56% |
| 2021 | 11.38% | 7.56% |
| 2020 | 10.58% | 16.65% |
| 2019 | 9.07% | -2.79% |
| 2018 | 9.33% | 82.23% |
| 2017 | 5.12% | 28.32% |
| 2016 | 3.99% | -654.17% |
| 2015 | -0.72% | -136.00% |
| 2014 | 2.00% | -116.13% |
| 2013 | -12.40% | 64.46% |
| 2012 | -7.54% | -76.45% |
| 2011 | -32.02% | -370.44% |
| 2010 | 11.84% | -22.36% |
| 2009 | 15.25% | 15.27% |
| 2008 | 13.23% | -4.41% |
| 2007 | 13.84% | 14.10% |
| 2006 | 12.13% | -7.62% |
| 2005 | 13.13% | -10.68% |
| 2004 | 14.70% | 46.12% |
| 2003 | 10.06% | 100.80% |
| 2002 | 5.01% | -26.00% |
| 2001 | 6.77% | 16,825.00% |
| 2000 | 0.04% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 15.48% | -96.16% |
US
|
|
| 0.00% | - |
DE
|
|
| 16.80% | -95.83% |
US
|
|
| 18.67% | -95.37% |
SA
|
|
| 0.00% | - |
MY
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.